Epicore Biosystems: Funding, Investors & Team (Oct 2026)
Epicore Biosystems, Inc. has created a unique wearable microfluidic platform that resembles human skin and has the ability to examine tiny sweat droplets for various health-related indicators including proteomics, inflammation markers, hydration levels, and other biomarkers. This advanced technology allows for personalized monitoring and management of health, performance, and nutrition. The development of Epicore's wearable sensors is the result of extensive research in microfluidics and soft materials conducted by Prof. John Rogers and Dr. Roozbeh Ghaffari at Northwestern University's Querrey-Simpson Institute for Biolectronics over a span of more than 20 years.
Epicore Biosystems has raised $46.2M across 5 funding rounds on record, the most recent a Series B of $6.0M announced in May 2025.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Epicore Biosystems Company Profile and Key Stats
Latest funding round on record: May 2025.
Epicore Biosystems Funding Rounds
1 of 5 rounds was announced without a disclosed amount and is excluded from the total.
Epicore Biosystems raised $4.7M in an undisclosed round announced in Nov 2021.
3 months later, a Series A of $9.5M was announced in Feb 2022.
1.9 years later, an undisclosed round was announced in Jan 2024 with no disclosed amount.
1.1 years later, a Series B of $26.0M was announced in Feb 2025.
3 months later, a Series B of $6.0M was announced in May 2025.
Epicore Biosystems Founders and Leadership Team
Contact details for the Epicore Biosystems team: 3 of 3 have an email address on file.
Start 14-day free trial →Epicore Biosystems Funding Compared to Other Health Care Startups
Epicore Biosystems' latest round of $6.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Epicore Biosystems in Health Care and Cambridge
Companies Similar to Epicore Biosystems
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Epicore Biosystems Funding FAQs
What does Epicore Biosystems do?
Epicore Biosystems, Inc. has created a unique wearable microfluidic platform that resembles human skin and has the ability to examine tiny sweat droplets for various health-related indicators including proteomics, inflammation markers, hydration levels, and other biomarkers. This advanced technology allows for personalized monitoring and management of health, performance, and nutrition. The development of Epicore's wearable sensors is the result of extensive research in microfluidics and soft materials conducted by Prof. John Rogers and Dr. Roozbeh Ghaffari at Northwestern University's Querrey-Simpson Institute for Biolectronics over a span of more than 20 years.
How much funding has Epicore Biosystems raised?
Epicore Biosystems has raised $46.2M across 5 rounds on record. The most recent is a Series B of $6.0M announced in May 2025.
When did Epicore Biosystems last raise funding?
Epicore Biosystems' most recent funding round on record is a Series B of $6.0M, announced in May 2025.
Who founded Epicore Biosystems?
FundedIQ lists Aj Aranyosi (Founder), Stephen Lee (Founder) at Epicore Biosystems.
Who is the CEO of Epicore Biosystems?
Roozbeh Ghaffari is listed as CEO at Epicore Biosystems.
Where is Epicore Biosystems headquartered?
Epicore Biosystems is based in Cambridge, Massachusetts, United States.
How many employees does Epicore Biosystems have?
Epicore Biosystems is in the 11-50 employee band.
How does Epicore Biosystems' funding compare to other Health Care startups?
Epicore Biosystems' latest round of $6.0M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Epicore Biosystems Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Epicore Biosystems is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.